Skip to main content
Autobound logo

Biogen news in 2026: 18 dated events

The latest Biogen event on this page is dated Sep 17, 2026. globenewswire.com reported: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents...

Public (BIIB)Biotechnology Research10,000+ employeesbiogen.comLinkedIn

Dated events
20
Last 90 days
11
Latest
Sep 17, 2026

News · latest 10

Latest Biogen news

  1. Launch
    Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents...Biogen announced the publication of results from a Phase 3 study of its drug EMPAVELI® (pegcetacoplan) in the Clinical Journal of the American Society of Nephrology.
    globenewswire.com
  2. Launch
    LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Approved in Japan for the Treatment of Early Alzheimer’s DiseaseWith Eisai Co., Ltd.
    globenewswire.com
  3. Recognition
    Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s DiseaseBiogen's drug LEQEMBI® (lecanemab) received a final positive recommendation supporting public reimbursement for early Alzheimer’s disease from Canada’s Drug Agency (CDA-AMC).
    globenewswire.com
  4. Integration
    Veeva Vault CRM Selected by BiogenWith Veeva Systems
    prnewswire.com
  5. Acquisition
    Biogen Completes Acquisition of Ray TheraBiogen has completed its acquisition of Ray Thera, a private biotechnology company, in a deal valued at up to $1 billion.
    pharmabiz.net
  6. Acquisition
    Biogen Completes Acquisition of RayThera Inc.Biogen has completed its acquisition of RayThera Inc., a biotechnology company focused on immunology therapies.
    globenewswire.com
  7. Revenue
    Biogen Boosts Profit Forecast with Growth Across Alzheimer's, Rare Disease PortfolioBiogen reported revenues of $2.736 billion, beating the consensus of $2.458 billion.
    benzinga.com
  8. Earnings
    Biogen reports Q2 2026: $2.74B revenue, GAAP EPS $0.66, Non‑GAAP EPS $3.60Biogen reported second-quarter 2026 GAAP diluted EPS of $0.66 and non-GAAP diluted EPS of $3.60.
    tradingview.com
  9. Partnership
    Biogen Inc. Stock Reacts After Quarterly Figures and Alzheimer Partnership with LillyWith Eli Lilly
    ad-hoc-news.de
  10. In development
    Biogen Wins FDA Approval for Subcutaneous Starter Dose of LeqembiWith Ionis Pharmaceuticals
    ca.finance.yahoo.com

Showing 10 of 20 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Biogen with the Signal API

One POST /v1/companies/enrich call with biogen.com returns Biogen news signals (news), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"biogen.com","signal_types":["news"],"limit":20}'

Same industry

News at related companies

Questions about Biogen news

What is the latest news on Biogen?
The newest event on this page is dated Sep 17, 2026. globenewswire.com reported: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents.... This page lists 20 dated events for Biogen, each with a source link.
What is going on with Biogen?
The 10 latest events on this page cover launch (2), recognition (1), integration (1), acquisition (2), revenue (1), earnings (1), partnership (1) and in development (1). The newest: Sep 17, 2026: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents... (globenewswire.com).

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →